Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
ROCK1 promotes B cell differentiation and proteostasis under stress through the heme-regulated proteins, BACH2 and HRI
Juan Rivera-Correa, Sanjay Gupta, Edd Ricker, Danny Flores-Castro, Daniel Jenkins, Stephen Vulcano, Swati P. Phalke, Tania Pannellini, Matthew M. Miele, Zhuoning Li, Nahuel Zamponi, Young-Bum Kim, Yurii Chinenov, Eugenia Giannopoulou, Leandro Cerchietti, Alessandra B. Pernis
Juan Rivera-Correa, Sanjay Gupta, Edd Ricker, Danny Flores-Castro, Daniel Jenkins, Stephen Vulcano, Swati P. Phalke, Tania Pannellini, Matthew M. Miele, Zhuoning Li, Nahuel Zamponi, Young-Bum Kim, Yurii Chinenov, Eugenia Giannopoulou, Leandro Cerchietti, Alessandra B. Pernis
View: Text | PDF
Research Article Aging Immunology

ROCK1 promotes B cell differentiation and proteostasis under stress through the heme-regulated proteins, BACH2 and HRI

  • Text
  • PDF
Abstract

The mechanisms utilized by differentiating B cells to withstand highly damaging conditions generated during severe infections, like the massive hemolysis that accompanies malaria, are poorly understood. Here, we demonstrate that ROCK1 regulates B cell differentiation in hostile environments replete with pathogen-associated molecular patterns (PAMPs) and high levels of heme by controlling 2 key heme-regulated molecules, BACH2 and heme-regulated eIF2α kinase (HRI). ROCK1 phosphorylates BACH2 and protects it from heme-driven degradation. As B cells differentiate, furthermore, ROCK1 restrains their pro-inflammatory potential and helps them handle the heightened stress imparted by the presence of PAMPs and heme by controlling HRI, a key regulator of the integrated stress response and cytosolic proteotoxicity. ROCK1 controls the interplay of HRI with HSP90 and limits the recruitment of HRI and HSP90 to unique p62/SQSTM1 complexes that also contain critical kinases like mTOR complex 1 and TBK1, and proteins involved in RNA metabolism, oxidative damage, and proteostasis like TDP-43. Thus, ROCK1 helps B cells cope with intense pathogen-driven destruction by coordinating the activity of key controllers of B cell differentiation and stress responses. These ROCK1-dependent mechanisms may be widely employed by cells to handle severe environmental stresses, and these findings may be relevant for immune-mediated and age-related neurodegenerative disorders.

Authors

Juan Rivera-Correa, Sanjay Gupta, Edd Ricker, Danny Flores-Castro, Daniel Jenkins, Stephen Vulcano, Swati P. Phalke, Tania Pannellini, Matthew M. Miele, Zhuoning Li, Nahuel Zamponi, Young-Bum Kim, Yurii Chinenov, Eugenia Giannopoulou, Leandro Cerchietti, Alessandra B. Pernis

×

Figure 3

ROCK1 phosphorylates BACH2 and controls its stability.

Options: View larger image (or click on image) Download as PowerPoint
ROCK1 phosphorylates BACH2 and controls its stability.
Purified CD23+ B ...
Purified CD23+ B cells from WT (black) and CD23-Rock1 (orange) mice were cultured with αIgM (5 μg/mL) + αCD40 (5 μg/mL), ± combinations of a TLR9-L (1 μg/mL) and heme (60 μM) for 3 days. (A) RT-qPCR showing Prdm1 expression relative to WT TLR9-L treatment, whose value was set at 1. Data are from 3 independent experiments and show mean ± SEM; P value by 2-way ANOVA followed by Holm-Šídák test for multiple comparisons. -L, ligand; Prdm1, PR/SET domain 1; RT-q, quantitative reverse transcription. (B) Representative immunoblot of BACH2 protein levels in the presence of cycloheximide (CHX) added on day 3 to αIgM+αCD40+TLR9-L+heme conditions for 0, 3, or 6 hours. (C) Densitometry ratio of BACH2 to tubulin levels. Data pooled from 3 independent experiments and show mean ± SEM; P value by 2-way ANOVA followed by Holm-Šídák test for multiple comparisons. (D) FLAG-tagged BACH2 was immunoprecipitated from 293T cells and incubated with CA-ROCK1. p-BACH2 was detected with an anti–phospho-serine Ab recognizing a consensus site shared by ROCK1 and PKA followed by reprobing with an anti-BACH2 Ab. Data are representative of 3 independent experiments. (E) Schematic diagram (adapted from https://mutagenetix.utsouthwestern.edu/phenotypic/phenotypic_rec.cfm?pk=3232) showing the putative ROCK phosphorylation sites in murine BACH2 identified by mass spectrometry. (F) 293T cells were transfected with constructs expressing FLAG-tagged wild-type BACH2 (WT) or mutants of BACH2 (S376A=A376, S718A=A718, or both S376A and S718A=A376A718). Transfectants were treated ± cycloheximide (CHX) ± heme for 7 hours at day 2 after transfection. Data are representative of 3 independent experiments. (G) Heatmap of the z-score–scaled expression of selected genes involved in PB/PC differentiation in stimulated WT and CD23-Rock1 B cells. (H) Heatmap of the z-score–scaled expression of selected BACH2 targets in stimulated WT and CD23-Rock1 B cells. (I) GSEA plots show the enrichment of BACH2 targets (26) in CD23-Rock1 B cells stimulated as indicated. *P value < 0.05 and ****P value < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts